CorMedix Inc - 48 Year Dividend Yield History | CRMD

Historical dividend payout and yield for CorMedix Inc (CRMD) since 1971. The current TTM dividend payout for CorMedix Inc (CRMD) as of February 15, 2019 is $0.00. The current dividend yield for CorMedix Inc as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.178B $0.000B
CorMedix Inc. is a development-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix's goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications. The Company's therapeutic candidates for cardiorenal disease may be small molecules, biologicals, devices and/or diagnostics (tests) that enable therapy. Its product pipeline includes: CRMD001, a unique formulation Deferiprone which is in development to prevent Contrast-Induced Acute Kidney Injury and to slow progression of Chronic Kidney Disease; CRMD002, a diagnostic test for urinary labile iron; CRMD003 (Neutrolin?, an antimicrobial/anticoagulant solution) is in development to prevent Catheter Related Bloodstream Infection; CRMD004, a pressure sensitive gel which has many uses, including extending the benefits of Neutrolin?. CorMedix Inc. is based in Summit, New Jersey.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76